Revvity, Inc.

NYSE:RVTY

Medical - Diagnostics & Research

Healthcare
$152.43 -3.36%

-$3.40 today

Market cap
$17.02B
Beta
1.11
P/E (TTM)
45.4
EPS (TTM)
$2.15
Dividend yield
0.29%
52W Low $81.22High $118.30

Volume 1.09M

Average 1.27M

RVTY Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Revvity, Inc.NYSE: RVTY

Weighted Avg Shares · Q2 FY2026 · quarter ended Jul 2026

Weighted avg shares declines year over year

Q2 FY2026 weighted avg shares of 111.75M shares fell 4.9% year over year, ahead of the -5.7% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 0.1% from the prior quarter. Over 3 fiscal years it compounded at -3.5% a year.

Context

  • Weighted avg shares increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -4.9% holds above the trailing-twelve-month pace of -5.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
111.75M-0.1% QoQ
Last fiscal yearDec 2025
113.21M-7.8% YoY
LTMJul 2026
113.64M-5.7% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.9%——
1 year-7.8%——
3-year CAGR-3.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
113.21M USD
Year-over-year change
-7.8%
4-year CAGR
-0.6%

Weighted Avg Shares vs competitors

How RVTY compares with its peers on the latest reported figures

  • RVTY's LTM Jul 2026 weighted avg shares of 113.64M shares is the 6th highest of the 11 companies compared; the peer median is 115.49M shares.
  • Its year-over-year change of -5.7% is the lowest of 11, against a peer median of -1.8%.
  • Over three fiscal years its annual growth of -3.5% compares with a peer median of -1.1%.
RVTY Competitors Peer median
Weighted Avg Shares for RVTY and competitors
Company Period LTM YoY 3-year CAGR
DHRDanaher CorporationLTM Sep 2026706.08M -1.7%-0.8%
TMOThermo Fisher Scientific Inc.LTM Sep 2026372.25M -1.8%-1.4%
AAgilent Technologies, Inc.LTM Jul 2026282.75M -1.2%-1.8%
QGENQiagen N.V.LTM Jun 2026209.5M -4.1%-2.0%
TECHBio-Techne CorporationLTM Sep 2026156.12M -0.3%-0.3%
RVTYRevvity, Inc.LTM Jul 2026113.64M -5.7%-3.5%
WATWaters CorporationLTM Jul 202674.85M +26.0%-0.3%
CRLCharles River Laboratories International, Inc.LTM Jun 202648.97M -3.2%-0.8%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.9M -3.2%-2.9%
MTDMettler-Toledo International Inc.LTM Jun 202620.32M -2.9%-2.9%
MLABMesa Laboratories, Inc.LTM Mar 20265.51M +1.8%+1.2%
Peer median (excluding RVTY) 115.49M-1.8%-1.1%

Competitors are the stored peer set for RVTY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.83B3.31B2.75B2.76B2.86B
Cost of Revenue1.55B1.55B1.43B1.43B1.34B
Gross Profit2.28B1.76B1.32B1.32B1.52B
Gross Margin59.6%53.2%48.1%48.0%53.1%
Research & Development200.34M221.62M216.58M196.84M215.84M
Selling, General & Admin741.61M757.99M706.12M715.3M945.29M
Operating Expenses941.95M979.61M922.7M912.14M1.16B
Depreciation & Amortization311.44M427M431.77M427.85M405.34M
EBITDA1.62B1.18B713.56M840.25M765.8M
EBITDA Margin42.2%35.7%25.9%30.5%26.8%
Operating Income1.34B781.12M399.49M410.52M356.64M
Operating Margin35.0%23.6%14.5%14.9%12.5%
Interest Income2.24M3.59M72.13M73.19M31.1M
Interest Expense102.13M103.96M98.81M96.28M92.19M
Other Income / Expenses(136.42M)(129.29M)(216.52M)(94.39M)(88.36M)
Income Before Tax1.2B651.84M182.98M316.13M268.28M
Pre-Tax Margin31.4%19.7%6.7%11.5%9.4%
Income Tax Expense314.15M139.16M3.47M33.06M25.8M
Net Income943.16M569.18M(118.38M)295.83M241.68M
Net Margin24.6%17.2%-4.3%10.7%8.5%
EPS (Basic)8.124.51(0.95)2.412.08
EPS (Diluted)8.084.50(0.95)2.412.08
Weighted Avg Shares116.17M126.16M124.7M122.76M113.21M
Weighted Avg Shares (Diluted)116.67M126.43M124.81M122.82M113.21M

Revvity, Inc.

NYSE:RVTY

Intrinsic Alpha fair value

Locked

Current Price

$152.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.